lorazepam has been researched along with trazodone in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Levine, BS; Pestaner, JP; Ripple, MG; Smialek, JE | 1 |
Cuenca, PJ; Hoefle, JD; Holt, KR | 1 |
Camacho, A; Ng, B | 1 |
Inouye, SK | 1 |
Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR | 1 |
Coulier, B; Devresse, A; Gielen, I; Maldague, P; Pierard, F | 1 |
3 review(s) available for lorazepam and trazodone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Lethal combination of tramadol and multiple drugs affecting serotonin.
Topics: Adult; Alcoholism; Analgesics, Opioid; Cyclohexanols; Dibenzothiazepines; Drug Interactions; Fatal Outcome; Humans; Lorazepam; Male; MEDLINE; Mental Processes; Quetiapine Fumarate; Receptors, Serotonin; Seizures; Selective Serotonin Reuptake Inhibitors; Smoking; Tramadol; Trazodone; Venlafaxine Hydrochloride | 2000 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans; Lorazepam; Quality of Health Care; Risk Factors; Trazodone | 2006 |
10 other study(ies) available for lorazepam and trazodone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Seizure secondary to citalopram overdose.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Overdose; Emergency Medical Services; Humans; Lorazepam; Male; Seizures; Suicide, Attempted; Tachycardia, Supraventricular; Trazodone; Treatment Outcome | 2004 |
Methylphenidate for alpha-interferon induced depression.
Topics: Affect; Aged; Antineoplastic Agents; Central Nervous System Stimulants; Depressive Disorder; Humans; Hypnotics and Sedatives; Interferon alpha-2; Interferon-alpha; Lorazepam; Male; Melanoma; Methylphenidate; Psychiatric Status Rating Scales; Pyridines; Recombinant Proteins; Trazodone; Zolpidem | 2006 |
A nonopioid procedure for outpatient opioid detoxification.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult | 2011 |
Focal parietal necrosis of the sigmoid due to atypical neuroleptics: a case report.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Citalopram; Clopenthixol; Dibenzothiazepines; Drug Overdose; Enterocolitis, Necrotizing; Humans; Lamotrigine; Lorazepam; Male; Quetiapine Fumarate; Schizoid Personality Disorder; Trazodone; Triazines | 2012 |